All In Biotech

Free tool

FAERS Monitor: Primatene Mist

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205920 or its brand name (Primatene Mist, Epinephrine). Reports on generic versions are filed under their own applications.

Reports

496

Serious

273

55% of reports

Hospitalization

53

Death reported

21

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective94
  • dyspnoea60
  • asthma33
  • chest pain31
  • throat irritation29
  • burning sensation28
  • cough25
  • dizziness23
  • heart rate increased19
  • headache17
  • tremor16
  • condition aggravated15
  • pharmaceutical product complaint15
  • incorrect dose administered14
  • palpitations14

Reports by year received

View as table
YearReports
200417
200511
200642
200717
2008112
200914
201013
201118
201216
20131
20143
20153
20163
20182
201920
202034
202137
202231
202331
202415
202529
202627

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,663 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
throat irritationSignal2927.419.3713
pharmaceutical product complaintSignal1524.514.9315
burning sensationSignal2816.911.8405
asthmaSignal3312.48.9336
heart rate increasedSignal198.15.2112
chest painSignal317.15.0158
palpitationsSignal145.13.042
dyspnoeaSignal604.53.5164
tremorSignal164.12.535
coughSignal253.82.649
drug ineffectiveSignal943.02.5134
incorrect dose administeredSignal142.61.612
condition aggravatedSignal152.11.38
dizziness232.01.310
headache171.10.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.